statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hutchmed (China) Limited (HCM) has released an update. HUTCHMED (China) Limited is set to present new and updated data on its cancer treatment comp...

HUTCHMED to Unveil New Cancer Drug Data at AACR 2024

This indicator may be signaling that HCM's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

HUTCHMED (China) (HCM, $16.77) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

HUTCHMED (China) (HCM, $16.85) entered Downtrend as Momentum indicator drops below 0 level on Mar 27, 2024

This is a Bearish indicator signaling HCM's price could decline from here. Traders may explore shorting the stock or put options...

HUTCHMED (China) (HCM, $16.65) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 26, 2024

HCM's total volume now sits at 582.2K. The +-0.35% price change was insignificant, leaving IBM's price at $17.28...

The volume for HUTCHMED (China) stock increased for one day, resulting in a record-breaking daily growth of 400% of the 65-Day Volume Moving Average

This is a signal that HCM's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

HUTCHMED (China) (HCM, $16.79) RSI Indicator left the overbought zone on March 14, 2024

HUTCHMED (China) (HCM, $18.56) RSI Indicator left the overbought zone on March 13, 2024

This price move could be a signal that HCM may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

HUTCHMED (China) (HCM, $18.56) price may drop as it broke higher Bollinger Band on Mar 13, 2024

HUTCHMED (China) (HCM, $14.52) entered Downtrend as Momentum indicator drops below 0 level on Mar 07, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

HUTCHMED (China) (HCM, $13.84) price exceeded its 50-day Moving Average on March 05, 2024

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

Volume	155,159.00
52-Wk High	$20.73
52-Wk Low	$10.68

Period	Estimated	Reported	Surprise	Result
Q4'23	-$1.08	--	--	N/A
Q1'23	--	-$0.05	--	N/A
Q4'22	-$1.02	-$1.02	--	EXPECTED
Q3'22	--	-$0.70	--	N/A
Q2'22	-$0.72	-$0.72	--	EXPECTED

HCM Hutchison China MediTech

About

Feed

News

Sentiment

Earnings

Fundamentals